Application of Operations Research in Clinical Supplies, Novo Nordisk
Julie Lehmbeck and Karoline Foverskov. ORbit (Danish Operations Research Society). 30;10-12
Whether you're interested in the current clinical trial management industry trends or want to know more about the latest FDA requirements, our collection of clinical trial articles will keep you up to date on what's happening now in clinical research news.
Clinical Trial Articles
2018
2017
Essential Tools. Co-authored by Mélanie Bodnar-Wachtel, PhD and Tanja Schubert, PhD
This article is taken from European Biopharmaceutical Review April 2017, pages 34-38. © Samedan Ltd.
This article is taken from International Clinical Trials August 2017, pages 46-48. © Samedan Ltd
2016
Judith Falloon, Fei Ji, Craig Curtis et al. A phase 1a, first-in-human, randomized study of a respiratorysyncytial virus F protein vaccine with and without a toll-likereceptor-4 agonist and stable emulsion adjuvant. Science Direct Journal. April 2016.
Jeffrey Heilbraun. Off-target Blood Pressure Effects in Biopharmaceutical Therapeutic Treatment Development: Points to Consider. JCS. October 2016.
Kristin Mauri, PMP, Enterprise Quality Management of Clinical Trials, April 2016.
Clare Jackson, Utku Ozdemir, Liz Moench. Take a Chance. ICT. February 2016.
2014
Herron D. The New Road of Cardio-Oncology in Clinical Development. Applied Clinical Trials. April 1, 2014.
Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ, Knost JA, Pathiraja K, Langdon RB, Yao S, Lu BD. A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumuma
2013
Borradaile K, Duffy K, O'Neal M. A Potential New Approach to Assessing PFS in Solid Tumor Studies. International Clinical Trials, May 2013.
O'Neal M, Strafaci J, Scarimbolo R, and Van Heertum R. A Paradigm in Evolution. European Pharmaceutical Contractor (EPC) March 2013.
2012
Yu HJ, Miller CG, Flitcraft D. Metrics in Medical Imaging: Changing the Picture. ACRP: The Monitor. August 2012.
Johnson G. Successful Technology Integration Partnerships: A Coalition of the Willing. PharmaVOICE. June 2012.
2011
van Meurs P, Miller CG. Image Conscious: New FDA Guidance. Samedan Ltd. 2011 Dec: 24-28.
Spano Lander A and Lander, Reta C Rupich. No Limits: The Evolution of DXA. International Clinical Trials, February, 2011.
2010
Borradaile K, Robert F, O'Neal M, Byrne K.
Webber B.
Ahmad H.
2009
Weinstein M. An Albatross and an Opportunity. View on Clinical Operations. 2009 Jun.
2007
Claypool, B. Functional outsourcing: a better alternative to traditional outsourcing and EDC. Next Generation Pharmaceutical. 2007.
2006
Reiber J, Heyrich G, van Weert A. A Period of Refinement. European Pharmaceutical Contractor (EPC). 2006;100-102.
2004
Kradjian S, Baratelle A, Einstein SG, Kaslow DC. Development of a Charter for an Endpoint Assessmen
Miller CG, Noever K.
van Weert A, Reiber J.
van Weert A and Reiber J.
2003
Miller C, Noever K. Scanning data for clinical information. Good Clinical Practices Journal. 2003. 10;9:21-24.
Leader in Clinical Trial
Management Solutions
Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.
Quick Links:
Language:
Think a #CTMS implementation takes too much time and too many resources? It doesn’t have to. Learn how a configurab… https://t.co/yowxvVTyP3
We think you should have access to the full suite of #ClinicalDataManagement services to ensure high-quality, relia… https://t.co/jVuliQwFo3
A mid-study change to a new #IRT vendor can be required for a number of reasons and can introduce a certain amount… https://t.co/sU7akWjdCD
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/rlYiFYpR6G
Rapid #CTMS implementation shouldn’t mean sacrificing features and functionality. With a modular approach, a full-f… https://t.co/gwqFtB8lhe
How prepared are you for a #clinicaltrial transition? With proper planning, the impact to sites and patients can be… https://t.co/vOqwC5vzzd